Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 3, 2007, Pages 289-295

  Chen, Ying Yan ^a   Huang, Chung Ter ^a   Yao, Shu Man ^a   Chang, Yi Ching ^a   Shen, Pei Wun ^a   Chou, Chen Ying ^a   Li, Shu Ying ^a  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

Erythromycin resistant; GAS; Molecular epidemiology; Streptococcus pyogenes; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; M PROTEIN; PENICILLIN DERIVATIVE; STREPTOCOCCUS VACCINE; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHILD; CHILDHOOD DISEASE; COLONY FORMING UNIT; EMM GENE; EPIDEMIC; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCARLET FEVER; SEROTYPE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TAIWAN; VACCINATION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CHLORAMPHENICOL; CLINDAMYCIN; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; ERYTHROMYCIN; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; SCARLET FEVER; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; TAIWAN;

EID: 34347344797     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.01.013     Document Type: Article

References (39)

1. Bisno A.L. Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med. 325 (1991) 783-793
2. Borzani M., De Luca M., and Varotto F. A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy. J. Antimicrob. Chemother. 40 (1997) 457-458
3. Chen Y.Y., Yao S.M., Chou C.Y., Chang Y.C., Shen P.W., Huang C.T., Su H.P., and Li S.Y. Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002-2003. J. Med. Microbiol. 55 (2006) 1109-1114
4. Chiou C.S., Liao T.L., Wang T.H., Chang H.L., Liao J.C., and Li C.C. Epidemiology and molecular characterization of Streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999. J. Clin. Microbiol. 42 (2004) 3998-4006
5. Chuang I., Van Beneden C., Beall B., and Schuchat A. Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clin. Infect. Dis. 35 (2002) 665-670
6. Cleary P.P., Kaplan E.L., Handley J.P., Wlazlo A., Kim M.H., Hauser A.R., and Schlievert P.M. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 339 (1992) 518-521
7. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13 (2000) 470-511
8. Dale J.B., and Shulman S.T. Dynamic epidemiology of group A streptococcal serotypes. Lancet 359 (2002) 889
9. Dicuonzo G., Fiscarelli E., Gherardi G., Lorino G., Battistoni F., Landi S., De Cesaris M., Petitti T., and Beall B. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob. Agents Chemother. 46 (2002) 3987-3990
10. Doktor S.Z., Beyer J.M., Flamm R.K., and Shortridge V.D. Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes. J. Clin. Microbiol. 43 (2005) 150-155
11. Espinosa L.E., Li Z., Gomez B.D., Calderon J.E., Rodriguez R.S., Sakota V., Facklam R.R., and Beall B. M protein gene type distribution among group A streptococcal clinical isolates recovered in Mexico City, Mexico, from 1991 to 2000, and Durango, Mexico, from 1998 to 1999, overlap with type distribution within the United States. J. Clin. Microbiol. 41 (2003) 373-378
12. Grivea I.N., Al Lahham A., Katopodis G.D., Syrogiannopoulos G.A., and Reinert R.R. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis, phenotypic and genotypic analysis. Antimicrob. Agents Chemother. 50 (2006) 256-261
13. Hsueh P.R., Chen H.M., Huang A.H., and Wu J.J. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob. Agents Chemother. 39 (1995) 2239-2242
14. Hsueh P.R., Liu C.Y., and Luh K.T. Current status of antimicrobial resistance in Taiwan. Emerg. Infect. Dis. 8 (2002) 132-137
15. Hsueh P.R., Shyr J.M., and Wu J.J. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin. Infect. Dis. 40 (2005) 903-905
16. Hsueh P.R., Teng L.J., Lee C.M., Huang W.K., Wu T.L., Wan J.H., Yang D., Shyr J.M., Chuang Y.C., Yan J.J., Lu J.J., Wu J.J., Ko W.C., Chang F.Y., Yang Y.C., Lau Y.J., Liu Y.C., Leu H.S., Liu C.Y., and Luh K.T. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes, SMART Program 2001 Data. Antimicrob. Agents Chemother. 47 (2003) 2152-2157
17. Hu M.C., Walls M.A., Stroop S.D., Reddish M.A., Beall B., and Dale J.B. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect. Immun. 70 (2002) 2171-2177
18. Johnson D.R., Stevens D.L., and Kaplan E.L. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J. Infect. Dis. 166 (1992) 374-382
19. Kim S., and Lee N.Y. Epidemiology and antibiotic resistance of group A streptococci isolated from healthy schoolchildren in Korea. J. Antimicrob. Chemother. 54 (2004) 447-450
20. Kiska D.L., Thiede B., Caracciolo J., Jordan M., Johnson D., Kaplan E.L., Gruninger R.P., Lohr J.A., Gilligan P.H., and Denny Jr. F.W. Invasive group A streptococcal infections in North Carolina, epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J. Infect. Dis. 176 (1997) 992-1000
21. Kotloff K.L., Corretti M., Palmer K., Campbell J.D., Reddish M.A., Hu M.C., Wasserman S.S., and Dale J.B. Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults, phase 1 trial. JAMA 292 (2004) 709-715
22. Kurzynski T.A., and Van Holten C.M. Evaluation of techniques for isolation of group A streptococci from throat cultures. J. Clin. Microbiol. 13 (1981) 891-894
23. Li Z., Sakota V., Jackson D., Franklin A.R., and Beall B. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J. Infect. Dis. 188 (2003) 1587-1592
24. Lin Y.C., Yao S.M., Yan J.J., Chen Y.Y., Hsiao M.J., Chou C.Y., Su H.P., Wu H.S., and Li S.Y. Molecular epidemiology of Bordetella pertussis in Taiwan, 1993-2004, suggests one possible explanation for the outbreak of pertussis in 1997. Microbes. Infect. 8 (2006) 2082-2087
25. Malhotra-Kumar S., Lammens C., Chapelle S., Wijdooghe M., Piessens J., Van Herck K., and Goossens H. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003. Emerg. Infect. Dis. 11 (2005) 939-942
26. Martin J.M., Green M., Barbadora K.A., and Wald E.R. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N. Engl. J. Med. 346 (2002) 1200-1206
27. McGregor K.F., and Spratt B.G. Identity and prevalence of multilocus sequence typing-defined clones of group A streptococci within a hospital setting. J. Clin. Microbiol. 43 (2005) 1963-1967
28. McNeil S.A., Halperin S.A., Langley J.M., Smith B., Warren A., Sharratt G.P., Baxendale D.M., Reddish M.A., Hu M.C., Stroop S.D., Linden J., Fries L.F., Vink P.E., and Dale J.B. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41 (2005) 1114-1122
29. Musser J.M., Kapur V., Szeto J., Pan X., Swanson D.S., and Martin D.R. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein, recent intercontinental spread of a subclone causing episodes of invasive disease. Infect. Immun. 63 (1995) 994-1003
30. O'Brien K.L., Beall B., Barrett N.L., Cieslak P.R., Reingold A., Farley M.M., Danila R., Zell E.R., Facklam R., Schwartz B., and Schuchat A. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35 (2002) 268-276
31. Reinert R.R., Lutticken R., Sutcliffe J.A., Tait-Kamradt A., Cil M.Y., Schorn H.M., Bryskier A., and Al Lahham A. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrob. Agents Chemother. 48 (2004) 1369-1373
32. Richter S.S., Heilmann K.P., Beekmann S.E., Miller N.J., Miller A.L., Rice C.L., Doern C.D., Reid S.D., and Doern G.V. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41 (2005) 599-608
33. Shulman S.T., Stollerman G., Beall B., Dale J.B., and Tanz R.R. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin. Infect. Dis. 42 (2006) 441-447
34. Shulman S.T., Tanz R.R., Kabat W., Kabat K., Cederlund E., Patel D., Li Z., Sakota V., Dale J.B., and Beall B. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin. Infect. Dis. 39 (2004) 325-332
35. Szczypa K., Sadowy E., Izdebski R., and Hryniewicz W. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J. Antimicrob. Chemother. 54 (2004) 828-831
36. Tyrrell G.J., Lovgren M., Forwick B., Hoe N.P., Musser J.M., and Talbot J.A. M types of group a streptococcal isolates submitted to the National Centre for Streptococcus (Canada) from 1993 to 1999. J. Clin. Microbiol. 40 (2002) 4466-4471
37. Whatmore A.M., Kapur V., Sullivan D.J., Musser J.M., and Kehoe M.A. Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol. Microbiol. 14 (1994) 619-631
38. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., Reingold A., Cieslak P.R., Pilishvili T., Jackson D., Facklam R.R., Jorgensen J.H., and Schuchat A. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348 (2003) 1737-1746
39. Yan J.J., Liu C.C., Ko W.C., Hsu S.Y., Wu H.M., Lin Y.S., Lin M.T., Chuang W.J., and Wu J.J. Molecular analysis of group A streptococcal isolates associated with scarlet fever in southern Taiwan between 1993 and 2002. J. Clin. Microbiol. 41 (2003) 4858-4861